DND PharmaTech Inc banner
D

DND PharmaTech Inc
KOSDAQ:347850

Watchlist Manager
DND PharmaTech Inc
KOSDAQ:347850
Watchlist
Price: 78 100 KRW -1.01% Market Closed
Market Cap: ₩3.4T

DND PharmaTech Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

DND PharmaTech Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
D
DND PharmaTech Inc
KOSDAQ:347850
Other Items
-₩123.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Other Items
-₩528.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
OliX Pharmaceuticals Inc
KOSDAQ:226950
Other Items
-₩97.3B
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Voronoi Inc
KOSDAQ:310210
Other Items
₩23.5B
CAGR 3-Years
N/A
CAGR 5-Years
19%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Other Items
-₩202.5B
CAGR 3-Years
N/A
CAGR 5-Years
-48%
CAGR 10-Years
-26%
A
ABL Bio Inc
KOSDAQ:298380
Other Items
₩3.1B
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

DND PharmaTech Inc
Glance View

Market Cap
3.4T KRW
Industry
Biotechnology

DND PharmaTech Inc is a KR-based company operating in Biotechnology industry. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2024-05-02. DND Pharmatech Inc is a Korea-based clinical-stage biotech company mainly engaged in the research and development in medicines. The firm's product pipeline mainly focuses on indications including metabolic disease, neurodegenerative and fibrotic diseases. In addition, the Company is engaged in the research and development of therapeutic medicines used for diabetes, obesity and nonalcoholic steatohepatitis as well as others.

Intrinsic Value
3 699.67 KRW
Overvaluation 95%
Intrinsic Value
Price
D

See Also

What is DND PharmaTech Inc's Other Items?
Other Items
-123.8m KRW

Based on the financial report for Dec 31, 2024, DND PharmaTech Inc's Other Items amounts to -123.8m KRW.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett